International Journal of Nephrology / 2023 / Article / Tab 3 / Research Article
Efficacy and Safety of Bedside Removal of Tunnelled Hemodialysis Catheter by Noninterventional Nephrologists among Adult Patients in the King Abdulaziz University Hospital Hemodialysis Centre in Jeddah: A Retrospective Cohort Study Table 3 Relationship between the tunnelled hemodialysis catheter removal procedure and patients’ demographics, lab results, and underlying medical conditions.
Variables TDC removal χ 2 valueIntervention radiologist/nephrologist no. (%) 13 (24.5%) Noninterventional nephrologist no. (%) 34 (64.2%) Surgeon no. (%) 6 (11.3%) Age 52.46 ± 22.55 51.88 ± 17.77 42.33 ± 17.46 0.69 0.502 BUN (mg/dl) 22.60 (11–52) 21.65 (4–56) 22.40 (14–41) 2 0.566 Creatinine (mg/dl) 716.15 ± 320.22 763.56 ± 336.16 926.5 ± 316.511 0.85 0.433 Platelets count (×10/mm3 ) 163 (66–271) 205.5 (65–592) 192 (81–225) 2 0.37 PTT (sec) 31.10 (26–119) 31.85 (22–178) 32.35 (28–42) 2 0.984 INR 1.10 (1–3) 1.10 (1–4) 1.12 (1–3) 2 0.956 WBCs (×10/mm3 ) 7.92 (4–20) 8.42 (4–25) 10.20 (8–19) 2 0.346 1PT 13 (11–17) 12.20 (10–44) 12.60 (11–16) 2.1 0.949 Hemoglobin (g/dl) 8.68 ± 1.46 8.01 ± 1.78 7.98 ± 1.36 0.8 0.453 Duration of catheter insertion (months) 21 ± 15 19 ± 9.7 24 ± 10.7 2.4 0.171 Gender Female 4 (19) 14 (66.7) 3 (14.3) 0.73 90.694 Male 9 (28.1) 20 (62.5) 3 (9.4) Underlying medical conditions Hypertension 5 (22.7) 14 (63.6) 3 (13.6) Diabetes mellitus, hypertension 5 (25.3) 13 (68.4) 1 (5.3) Diabetes mellitus, hypertension, dyslipidaemia 1 (25) 2 (50) 1 (25) 6.19 0.906 Diabetes mellitus 0 (0.0) 1 (100) 0 (0.0) Dyslipidaemia 1 (100) 0 (0.0) 0 (0.0) Hypertension, dyslipidaemia 0 (0.0) 1 (100) 0 (0.0) None 1 (20) 3 (60) 1 (20)
= one-way ANOVA test;
= Kruskal–Wallis test. TDC: tunnelled hemodialysis catheters; BUN: blood urea nitrogen; PTT: partial thromboplastin time; INR: international normalised ratio; PT: prothrombin time; WBC: white blood cell.